Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

mICRA statement of endorsement


Published: 07 June 2019

Version: 1.0

Print this document

Model Industry Collaborative Research Agreement (mICRA) Statement of Endorsement

We endorse the development of the model Industry Collaborative Research Agreement (mICRA) and commend its routine use for research collaborations involving industry, universities and the NHS.

As members of the working group developing a model agreement for industry collaborative research we participated in a rigorous process involving representatives and legal advisors of the key stakeholders in commercial clinical research.

This process resulted in agreement on the terms of a range of model agreements to support clinical research collaborations involving the pharmaceutical and biotechnology industries, academia and NHS organisations.

These agreement templates should make a major contribution to improving the speed, ease and efficiency of negotiating the terms under which individual collaborations are conducted and therefore help to ensure that the initiation of collaborative studies in the UK is not subject to unnecessary delay.

We therefore commend its routine use by all parties involved in industry collaborative research.

23 February 2011

mICRA working group members included:

Association of Medical Research Charities

Association of the British Pharmaceutical Industry

Association of UK University Hospitals

BioIndustry Association

Chief Scientist Office, Scotland

Department for Business, Innovation & Skills

Department of Health

Intellectual Property Office

Medical Research Council

Medical Schools Council

National Institute for Health Research

National Institute for Social Care and Health Research, Welsh Assembly Government

NHS Research Scotland

Northern Ireland Health and Social Care Research & Development

Wellcome Trust